SCHEMBL21152897

SCHEMBL21152897

CNc1ccc(COC(=O)C(C)S)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.41
KMT2A Q03164 5/20 0.38
MAPT P10636 4/20 0.38
MEN1 O00255 4/20 0.38
KDM4E B2RXH2 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ALDH1A1 P00352 2/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
THRB P10828 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
RECQL P46063 1/20 0.38
HIF1A Q16665 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TPSAB1 Q15661 2/20 0.37
PLG P00747 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10255243 0.86 APP (0.44) APPKMT2AMAPTMEN1KDM4E
SCHEMBL25046753 0.83 APP (0.41) APPKMT2AMAPTMEN1KDM4E
SCHEMBL3074673 0.81 APP (0.45) APPKMT2AMAPTMEN1KDM4E
SCHEMBL24642335 0.81 APP (0.45) APPKMT2AMAPTMEN1KDM4E
SCHEMBL25964987 0.80 SMN1; SMN2 (0.54) KMT2AMAPTMEN1KDM4ENPSR1
SCHEMBL21163456 0.79 APP (0.46) APPKMT2AMAPTMEN1KDM4E
SCHEMBL12285735 0.79 ALDH1A1 (0.60) APPKMT2AMAPTMEN1KDM4E
SCHEMBL17540919 0.79 ALDH1A1 (0.60) KMT2AMAPTALDH1A1HPGDL3MBTL1
SCHEMBL21788083 0.79 TOP2A (0.51) KMT2AMEN1ALDH1A1CYP3A4ALOX15
SCHEMBL11982012 0.79 APP (0.41) APPKMT2AMAPTMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190209702-A1 STEROIDS AND ANTIBODY-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190209702-A1 STEROIDS AND ANTIBODY-CONJUGATES THEREOF SERPINA6, NR3C1, NR3C2 APP 3633/4885KMT2A 4385/4885MAPT 2910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.